Stephan Wullschleger
Molecular Partners (Switzerland)(CH)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune Cell Function and Interaction, Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies
Most-Cited Works
- → TOR Signaling in Growth and Metabolism(2006)5,743 cited
- → Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control(2002)1,883 cited
- → A colorectal cancer classification system that associates cellular phenotype and responses to therapy(2013)963 cited
- → Identification of Protor as a novel Rictor-binding component of mTOR complex-2(2007)447 cited
- → Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice(2008)393 cited
- → PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells(2022)243 cited
- → Molecular Organization of Target of Rapamycin Complex 2(2005)236 cited
- → Tor2 Directly Phosphorylates the AGC Kinase Ypk2 To Regulate Actin Polarization(2005)213 cited
- → A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics(2015)207 cited
- → Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney(2011)177 cited